Tuberculosis of Breast

Kapan, Murat; Toksöz, Mehmet; Bakir, Sule; Sak, Müge; Evsen, Mehmet Sıddık; Bozkurt, Yaşar; Önder, Akın

doi:10.29333/ejgm/82856

Cited by 11 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Breast TB is treated with anti-TB treatment just like the pulmonary TB and the duration of the treatment stretches to six months. The six months duration of TB therapy is divided into two months of intensive-phase and four months of the continuation-phase [7].…”

Section: Discussionmentioning

confidence: 99%

Primary tuberculosis of the breast: A rare case

Gaxa¹,

Hlatshwayo²

2015

Case Rep Int

View full text Add to dashboard Cite

Introduction: Tuberculosis (TB) is a very common entity that is predominant in the developing countries. However, coming across TB of the breast is a rare, exceptional and an exciting experience. Primary breast TB incidence is reported to range between 0.025 and 0.1% in the developed countries compared to the incidence of breast TB in the developing countries which is approximated at 3-4.5% of TB cases. The breast is generally labeled as the body organ which is structured in such a manner that its environment is not conducive for the multiplication of the bacilli. Case Report: A case of a 32-year-old female presented with an occasionally painful left breast and left axillary lumps over a period of two months duration. She had been well with no remarkable past medical history. There is no history of previous trauma and she was not exposed to people with TB at home and at work. There are no respiratory system signs of TB. Biopsies of the left breast lump as well as that of the left axillary lump were performed and the diagnosis of TB breast and the left axillary was clinched. The patient was then put on anti-TB treatment. Conclusion: There are no specific

show abstract

Section: Discussionmentioning

confidence: 99%

Primary tuberculosis of the breast: A rare case

Gaxa¹,

Hlatshwayo²

2015

Case Rep Int

View full text Add to dashboard Cite

show abstract

“…6,7,8 Given the infrequency with which BTB is diagnosed, little research has been performed on the disease. Breast tuberculosis and BCA may present clinically in a very similar fashion leading to potential misdiagnosis 9,10 ; given that an accurate diagnosis is essential if the patient is to receive correct and timely treatment, this may be problematic. 8…”

Section: Introductionmentioning

confidence: 99%

Differentiation of breast tuberculosis and breast cancer using diffusion-weighted, T2-weighted and dynamic contrast-enhanced magnetic resonance imaging

Ramaema

Hift

2018

S. Afr. j. radiol.

View full text Add to dashboard Cite

BackgroundThe use of multi-parametric magnetic resonance imaging (MRI) in the evaluation of breast tuberculosis (BTB).ObjectivesTo evaluate the value of diffusion-weighted imaging (DWI), T2-weighted (T2W) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiating breast cancer (BCA) from BTB.MethodWe retrospectively studied images of 17 patients with BCA who had undergone pre-operative MRI and 6 patients with pathologically proven BTB who underwent DCE-MRI during January 2014 to January 2015.ResultsAll patients were female, with the age range of BTB patients being 23–43 years and the BCA patients being 31–74 years. Breast cancer patients had a statistically significant lower mean apparent diffusion coefficient (ADC) value (1072.10 ± 365.14), compared to the BTB group (1690.77 ± 624.05, p = 0.006). The mean T2-weighted signal intensity (T2SI) was lower for the BCA group (521.56 ± 233.73) than the BTB group (787.74 ± 196.04, p = 0.020). An ADC mean cut-off value of 1558.79 yielded 66% sensitivity and 94% specificity, whilst the T2SI cut-off value of 790.20 yielded 83% sensitivity and 83% specificity for differentiating between BTB and BCA. The homogeneous internal enhancement for focal mass was seen in BCA patients only.ConclusionMulti-parametric MRI incorporating the DWI, T2W and DCE-MRI may be a useful tool to differentiate BCA from BTB.

show abstract

“…It consists of six months' therapy, which includes two months of intensive-phase therapy and four months of continuationphase therapy [2]. The success rate of medical therapy approaches 95% with this sixmonth regime [10].…”

mentioning

confidence: 99%